{"id":"actiq-400-g-transmucosally","safety":{"commonSideEffects":[{"rate":"20%","effect":"Nausea"},{"rate":"15%","effect":"Vomiting"},{"rate":"10%","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL3652526","moleculeType":"Small molecule","molecularWeight":"431.52"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Fentanyl is a potent synthetic opioid that mimics the effects of endogenous opioids. It binds with high affinity to mu-opioid receptors, leading to inhibition of nociceptive transmission and modulation of pain perception.","oneSentence":"Fentanyl acts by binding to opioid receptors, primarily mu-opioid receptors, in the central nervous system to produce analgesia and euphoria.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:48:49.390Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Breakthrough cancer pain"}]},"trialDetails":[{"nctId":"NCT01780233","phase":"PHASE1","title":"Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv)","status":"COMPLETED","sponsor":"INSYS Therapeutics Inc","startDate":"2007-04","conditions":"Pain","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["fentanyl citrate"],"phase":"phase_1","status":"active","brandName":"Actiq® 400 µg transmucosally","genericName":"Actiq® 400 µg transmucosally","companyName":"INSYS Therapeutics Inc","companyId":"insys-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fentanyl acts by binding to opioid receptors, primarily mu-opioid receptors, in the central nervous system to produce analgesia and euphoria. Used for Breakthrough cancer pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}